Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

Overview of attention for article published in Lancet Neurology, June 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 34 news outlets
blogs: 4 blogs
twitter: 75 X users

patent: 8 patents
facebook: 9 Facebook pages

Readers on

mendeley: 462 Mendeley

So far, Altmetric has seen 9 public wall posts from 9 users.

Keeping Memories, 22 Jun 2017

Neurofilament light protein (NF-L) in plasma shows promise as a potential prognostic blood biomarker of disease onset and…

Saber IMSS, 12 Jun 2017

Desarrollan un test sanguíneo capaz de predecir la progresión de la Enfermedad de Huntington. Conoce esta #InnovaciónMédica #Sabe…

Huntington's Disease Society of America - HDSA Washington State Chapter, 10 Jun 2017

NfL in plasma shows promise as a potential prognostic blood biomarker of disease onset and progression in Huntington's disease.

Journal of Huntington's Disease, 09 Jun 2017

NfL in plasma shows promise as a potential prognostic blood biomarker of disease onset and progression in Huntington's disease.

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 5 additional Facebook posts.